Astera Labs, Inc.
ALAB
$71.20
-$0.44-0.61%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 13.00% | 24.77% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 13.00% | 24.77% | |||
| Cost of Revenue | 9.23% | 45.38% | |||
| Gross Profit | 14.33% | 18.86% | |||
| SG&A Expenses | -8.81% | 3.61% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.11% | 15.55% | |||
| Operating Income | 7,736.81% | 101.62% | |||
| Income Before Tax | 102.92% | 430.85% | |||
| Income Tax Expenses | 27.90% | -245.81% | |||
| Earnings from Continuing Operations | 28.75% | 425.47% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 28.75% | 425.47% | |||
| EBIT | 7,736.81% | 101.62% | |||
| EBITDA | 1,010.02% | 113.89% | |||
| EPS Basic | 26.13% | 419.42% | |||
| Normalized Basic EPS | 99.04% | 422.50% | |||
| EPS Diluted | 29.31% | 387.60% | |||
| Normalized Diluted EPS | 102.12% | 371.25% | |||
| Average Basic Shares Outstanding | 2.06% | 1.95% | |||
| Average Diluted Shares Outstanding | 0.31% | 13.22% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||